title: The political and ethical challenge of multi-drug resistant tuberculosis.
abstract: This article critically examines current responses to multi-drug resistant tuberculosis (MDR-TB) and argues that bioethics needs to be willing to engage in a more radical critique of the problem than is currently offered. In particular, we need to focus not simply on market-driven models of innovation and anti-microbial solutions to emergent and re-emergent infections such as TB. The global community also needs to address poverty and the structural factors that entrench inequalities-thus moving beyond the orthodox medical/public health frame of reference.
authors: Centre for Values, Ethics and the Law in Medicine, Sydney School of Public health, University of Sydney, Level 1, Medical Foundation Building, K25, Sydney, NSW, 2006, Australia, chris.degeling@sydney.edu.au.
authors: Chris
authors: C
authors: Degeling
authors: Christopher
authors: C
authors: Mayes
authors: Wendy
authors: W
authors: Lipworth
authors: Ian
authors: I
authors: Kerridge
authors: Ross
authors: R
authors: Upshur
mesh_terms: D021821:Communicable Diseases, Emerging; D014943:Global Health / Q000941:ethics*; D006801:Humans; D011057:Politics; D011203:Poverty; D011634:Public Health / Q000941:ethics; D064890:Social Determinants of Health; D018088:Tuberculosis, Multidrug-Resistant
references: J Med Philos. 2006 Jun;31(3):205-12
references: 16760100
references: J Antimicrob Chemother. 2011 Sep;66(9):1941-4
references: 21700626
references: Lancet. 2010 Jun 12;375(9731):2100-9
references: 20488518
references: Lancet Infect Dis. 2012 Mar;12(3):249-53
references: 22101066
references: Bioethics. 2010 Jun;24(5):218-25
references: 20500759
references: PLoS One. 2013;8(1):e54587
references: 23349933
references: Lancet Respir Med. 2014 Apr;2(4):321-38
references: 24717628
references: Int J Tuberc Lung Dis. 2014 Feb;18(2):155-9
references: 24429306
references: Tuberculosis (Edinb). 2014 Mar;94(2):183-5
references: 24388836
references: Clin Infect Dis. 2013 Jan;56(1):106-13
references: 23042970
references: Lancet. 2012 Jun 9;379(9832):2148; author reply 2148-9
references: 22682460
references: Int J Antimicrob Agents. 2012 Apr;39(4):295-9
references: 22341298
references: Nat Biotechnol. 2013 Feb;31(2):89-91
references: 23392485
references: Antimicrob Agents Chemother. 2013 Oct;57(10):4605-7
references: 23896479
references: Nat Rev Drug Discov. 2010 Sep;9(9):675-6
references: 20811374
references: Int J Tuberc Lung Dis. 2012 Aug;16(8):1005-14
references: 22762423
references: Bull World Health Organ. 2009 Jun;87(6):481-3
references: 19565127
references: Camb Q Healthc Ethics. 2007 Winter;16(1):97-108
references: 17345971
references: Lancet Infect Dis. 2014 Feb;14(2):102-3
references: 24605379
references: Br Med J. 1952 May 31;1(4769):1162-8
references: 14925408
references: Clin Infect Dis. 2007 Dec 1;45(11):1415-6
references: 17990221
references: Lancet Infect Dis. 2014 Apr;14(4):327-40
references: 24670627
references: Int J Tuberc Lung Dis. 2006 Nov;10(11):1185-7
references: 17131774
references: N Engl J Med. 2012 Sep 6;367(10):931-6
references: 22931261
references: Lancet Infect Dis. 2013 Jun;13(6):529-39
references: 23531391
references: J Law Med Ethics. 2004 Summer;32(2):243-51, 190-1
references: 15301189
references: Lancet Infect Dis. 2007 Aug;7(8):559-66
references: 17646029
references: Lancet. 2002 Jun 22;359(9324):2188-94
references: 12090998
references: Clin Pharmacol Ther. 2013 Jun;93(6):468-70
references: 23689211
references: Clin Infect Dis. 2009 Jan 1;48(1):1-12
references: 19035777
references: BMJ. 2012 Apr 03;344:e1782
references: 22491076
references: BMJ. 2009 Mar 31;338:b1025
references: 19336489
references: Anthropol Med. 2010 Aug;17(2):201-14
references: 20721757
references: Glob Public Health. 2012;7 Suppl 2:S127-43
references: 23039022
references: Health Aff (Millwood). 2010 Sep;29(9):1689-96
references: 20820028